A significant development is expected in the gene therapy market. It is anticipated to reach $36.55 billion by 2032. The growth is attributed to increasing demand for curative treatments and an expanding clinical pipeline. Further information on this trend can be found in the Denton Record-Chronicle, which provides details on the projected market growth and its driving factors.